Insight journal, Insight journal - Company

Alkermes: Partnering activity 2007-2014

Posted on 08 April 2014

Tags: , , ,

Alkermes, a fully integrated global biopharma company, is headquartered in Dublin, Ireland. It has emerged as a big biotech company applying the expertise to develop innovative medicines to improve patient outcomes. Its primary therapy focus areas are CNS disorders, such as schizophrenia, addiction and depression.Our partnering activity article looks in detail the deals entered into by Alkermes and the trends it follows.

The following figure shows the level of Alkermes partnering deal announcements since 2007.

Figure 1: Alkermes partnering deals 2007-2014

Figure 1: Alkermes partnering deals 2007-2014

Figure 1: Alkermes partnering deals 2007-2014

Source: Current Agreements, 2014

Alkermes is open to partnerships with pharmaceutical companies and research institutions and have partnered with a recent few in the last few years. Some of the companies that Alkermes has partnered with are Acceleron Pharma, Acorda Therapeutics, Alkermes, Cilag (Johnson & Johnson subsidiary) and Eli Lilly.

Although the predominant product pipeline of Alkermes deals with CNS disorders, the company has partnered widely in the public health therapy area.

The following table provides an overview of the partnering deals announced by Alkermes based on therapy area disclosed. Our report provides more detailed insight into the precise therapeutic target of each deal. See: Report: Partnering Agreements with Alkermes 2009-2014                                                                         

Figure 2: Alkermes partnering deals by therapy area 2007-2014

Figure 2: Alkermes partnering deals by therapy area 2007-2014

Figure 2: Alkermes partnering deals by therapy area 2007-2014

Source: Current Agreements, 2014

Further analysis of these deals shows that Alkermes has a preference for licensing deals similar to many other top pharmaceutical or big biotech companies. Such partnering deals provide the right for Alkermes to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments. The company has entered into several deals licensing its proprietary technology in respiratory and public health diseases applications.

The following table provides an overview of the partnering deals announced by Alkermes based on deal type disclosed.

Figure 3: Alkermes partnering deals by deal type 2007-2014

Figure 3: Alkermes partnering deals by deal type 2007-2014

Figure 3: Alkermes partnering deals by deal type 2007-2014

Source: Current Agreements, 2014

Alkermes has entered into licensing deals with Acceleron and Cilag (a subsidiary of Johnson & Johnson) for specific technology and marketing drug candidates in high valued deals. The following provides a summary of the top deals by headline value.

Figure 4: Top Alkermes partnering deals by headline value 2007-2014

Figure 4: Top Alkermes partnering deals by headline value 2007-2014

Figure 4: Top Alkermes partnering deals by headline value 2007-2014

 

Source: Current Agreements, 2014

Our report provides more detailed insight into the details of each deal. See: Report: Partnering Agreements with Alkermes 2009-2014

Alkermes partnering at Current Agreements

View all partnering deals for Alkermes: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

Full details on each deal can be found at CurrentAgreements (subscription required)

Or purchase report: Report: Partnering Agreements with Alkermes 2009-2014

More

Summary profile data for Alkermes

Partnering interests for Alkermes

M&A activity for Alkermes

 

Available reports from Current Partnering

Report: Partnering Agreements with Alkermes 2009-2014

Report: Partnering Deals and Alliances with Big Biotech 

 

Available resources for deal coverage for Alkermes      

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Alkermes company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cpbannerad300x150new1gif
rauconbadgejpg
e78banner300x150animgif
cpbannerad300x150new2gif
e79banner300x150gif
e78banner300x150animgif